Evidence map›Paper›PMID 35371099›Full record

ArticleFrontiers in immunology2022

Pro-Inflammatory Derangement of the Immuno-Interactome in Heart Failure.

Pavanish Kumar, Amanda Lim, Su Li Poh, Sharifah Nur Hazirah, Camillus Jian Hui Chua, Nursyuhadah Binte Sutamam, Thaschawee Arkachaisri, Joo Guan Yeo, Theo Kofidis, Vitaly Sorokin and 3 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. The Cardiohepatic Axis in Metabolic Disease: Liver to Heart.JACC. Basic to translational science · 2025
    Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Immunometabolism at the Heart of Cardiovascular Disease.JACC. Basic to translational science · 2023
    Review
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 1 country.

Pavanish KumarTranslational Immunology Institute, SingHealth Duke-NUS Academic Medical Centre, Singapore, Singapore.
Amanda LimTranslational Immunology Institute, SingHealth Duke-NUS Academic Medical Centre, Singapore, Singapore.
Su Li PohTranslational Immunology Institute, SingHealth Duke-NUS Academic Medical Centre, Singapore, Singapore.
Sharifah Nur HazirahTranslational Immunology Institute, SingHealth Duke-NUS Academic Medical Centre, Singapore, Singapore.
Camillus Jian Hui ChuaTranslational Immunology Institute, SingHealth Duke-NUS Academic Medical Centre, Singapore, Singapore.
Nursyuhadah Binte SutamamTranslational Immunology Institute, SingHealth Duke-NUS Academic Medical Centre, Singapore, Singapore.
Thaschawee ArkachaisriPaediatrics Academic Clinical Programme, SingHealth Duke-NUS Academic Medical Centre, Singapore, Singapore.
Joo Guan YeoTranslational Immunology Institute, SingHealth Duke-NUS Academic Medical Centre, Singapore, Singapore.
Theo KofidisNational University Heart Centre, Singapore, Singapore.
Vitaly SorokinNational University Heart Centre, Singapore, Singapore.
Carolyn S P LamDuke-NUS Medical School, Cardiovascular Academic Clinical Program, Singapore, Singapore.
Arthur Mark RichardsThe National University Health System (NUHS) Cardiovascular Research Institute, Singapore, Singapore.
Salvatore AlbaniTranslational Immunology Institute, SingHealth Duke-NUS Academic Medical Centre, Singapore, Singapore.
SingHealth Duke-NUS Academic Medical Centre · SGKK Women's and Children's Hospital · SGNational University Health System · SGNational Heart Centre Singapore · SGNational University Heart Centre Singapore · SG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic heart failure (HF) is a syndrome of heterogeneous etiology associated with multiple co-morbidities. Inflammation is increasingly recognized as a key contributor to the pathophysiology of HF. Heterogeneity and lack of data on the immune mechanism(s) contributing to HF may partially underlie the failure of clinical trials targeting inflammatory mediators. We studied the Immunome in HF cohort using mass cytometry and used data-driven systems immunology approach to discover and characterize modulated immune cell subsets from peripheral blood. We showed cytotoxic and inflammatory innate lymphoid and myeloid cells were expanded in HF patients compared to healthy controls. Network analysis showed highly modular and centralized immune cell architecture in healthy control immune cell network. In contrast, the HF immune cell network showed greater inter-cellular communication and less modular structure. Furthermore, we found, as an immune mechanism specific to HF with preserved ejection fraction (HFpEF), an increase in inflammatory MAIT and CD4 T cell subsets.

Indexed as

Heart FailureHumansImmunity, InnateLymphocytesStroke VolumeVentricular Function, Leftcardiovascular diseaseCyTOFheart failureimmunityinflammationnetwork biologysystems immunology

Identifiers

PMID35371099
PMCPMC8964981
OpenAlexW4220850888

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.